Two-thirds of U.S. adults say abortion pill should remain on market: poll
The poll also found that 78% of U.S. adults felt the decision to have an abortion should be left to a woman and her doctor.
Two-thirds of U.S. adults say that the abortifacient mifepristone should remain on the market, according to a poll published Tuesday.
While 66% of U.S. adults say mifepristone, which is used in most abortions in the country, should remain available on the market, while 24% say it should no longer be sold, according to a Washington Post-ABC News poll.
Mifepristone, which is used in conjunction with misoprostol to induce an abortion through 10 weeks of gestation, is at the center of an ongoing legal dispute after the Alliance Defending Freedom, a conservative legal group, filed a lawsuit arguing that the Food and Drug Administration did not properly review the drug before approving it in 2000.
The Supreme Court ruled last month that the drug could be accessed as usual while the legal challenge proceeds in court.
The poll also found that 78% of U.S. adults felt the decision to have an abortion should be left to a woman and her doctor compared to 18% who said it should be regulated by law.
The survey was conducted April 28-May 3 with 1,006 U.S. adults and it has a 3.5% error margin.